Gut Bacteria May Convert Choline Into Clot-Enhancing Compound

This article originally appeared here.
Share this content:
Gut Bacteria May Convert Choline Into Clot-Enhancing Compound
Gut Bacteria May Convert Choline Into Clot-Enhancing Compound

TUESDAY, April 25, 2017 (HealthDay News) -- Consuming excess choline raises levels of the bacteria-produced compound trimethylamine N-oxide (TMAO) and increases the tendency of platelets to clump together and form clots, according to a study published online April 24 in Circulation.

Weifei Zhu, Ph.D., from the Cleveland Clinic in Ohio, and colleagues prospectively recruited eight healthy vegans/vegetarians and 10 omnivores with no preceding one-month history of antibiotics or probiotics. Participants were given oral choline supplementation for two months.

The researchers found that both vegans/vegetarians and omnivores had significant (>10-fold) increases in plasma TMAO levels at both one and two months; they also had corresponding enhanced platelet aggregation responses to submaximal adenosine diphosphate. There was a dose-dependent correlation between plasma TMAO levels and platelet function. Change from baseline in TMAO level correlated significantly with change from baseline in platelet aggregation among all subjects. In a subsequent analysis, omnivores who had been examined in the absence of aspirin were started on aspirin for one month before baseline evaluation followed by two months of choline supplementation. Choline correlated with increases in fasting plasma TMAO levels and adenosine diphosphate-dependent platelet aggregation responses, although the degree was attenuated with aspirin therapy.

"These studies show for the first time a direct prothrombotic effect of dietary choline and elevated levels of the gut microbial metabolite TMAO in humans," the authors write. "They also suggest the platelet hyperresponsiveness mediated by elevated TMAO can be attenuated by a low dose of aspirin."

Two authors disclosed financial ties to the biopharmaceutical industry and are named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

For Hepatitis B Patients, Aspirin Tied to Lower Risk of HCC

For Hepatitis B Patients, Aspirin Tied to Lower ...

5 years of aspirin therapy linked to significantly lower incidence of hepatocellular carcinoma

High Percentage of HIV-Diagnosed Women Not in Care

High Percentage of HIV-Diagnosed Women Not in Care

62 percent of women with positive test had previously received the diagnosis but no care

CDC Updates Zika Guidance for Infant Care

CDC Updates Zika Guidance for Infant Care

Recommendations include evaluation and management of infants with possible infection

is free, fast, and customized just for you!

Already a member?

Sign In Now »